Lo Buglio, A.; Bellanti, F.; Carapellese, R.M.; Villani, R.; Sangineto, M.; Romano, A.D.; Vendemiale, G.; Serviddio, G.
Evaluating the Inflammatory Protein Ratio (IPR) as an Inflammation-Based Biomarker for Cancer Diagnosis. Int. J. Mol. Sci. 2025, 26, 4375.
https://doi.org/10.3390/ijms26094375
AMA Style
Lo Buglio A, Bellanti F, Carapellese RM, Villani R, Sangineto M, Romano AD, Vendemiale G, Serviddio G.
Evaluating the Inflammatory Protein Ratio (IPR) as an Inflammation-Based Biomarker for Cancer Diagnosis. International Journal of Molecular Sciences. 2025; 26(9):4375.
https://doi.org/10.3390/ijms26094375
Chicago/Turabian Style
Lo Buglio, Aurelio, Francesco Bellanti, Rosanna Maria Carapellese, Rosanna Villani, Moris Sangineto, Antonino Davide Romano, Gianluigi Vendemiale, and Gaetano Serviddio.
2025. "Evaluating the Inflammatory Protein Ratio (IPR) as an Inflammation-Based Biomarker for Cancer Diagnosis" International Journal of Molecular Sciences 26, no. 9: 4375.
https://doi.org/10.3390/ijms26094375
APA Style
Lo Buglio, A., Bellanti, F., Carapellese, R. M., Villani, R., Sangineto, M., Romano, A. D., Vendemiale, G., & Serviddio, G.
(2025). Evaluating the Inflammatory Protein Ratio (IPR) as an Inflammation-Based Biomarker for Cancer Diagnosis. International Journal of Molecular Sciences, 26(9), 4375.
https://doi.org/10.3390/ijms26094375
